Mostrando 2 resultados de: 2
Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b
ArticleAbstract: Polysaccharide-protein conjugates as vaccines have proven to be very effective in preventing HaemophPalabras claves:Autores:Cardoso F., Carmenate T., Chang J., Cosme K., Eugenio Hardy, Fernández-Santana V., Figueroa I., Hernández I., Heynngnezz L., Izquierdo M., Mawas F., Musacchio Lasa A., Peña L., Rodriguez A., Rodriguez M.C., Roy R., Toledo-Romani M.E., Valdés Y., Verez-Bencomo V.Fuentes:scopusPhase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers
ArticleAbstract: Since 1989, we have been involved in the development of a vaccine against Haemophilus influenzae typPalabras claves:Autores:Aguilar A., Alvarez Y., Baly A., Dfana J., Diaz M., Eugenio Hardy, Fernández-Santana V., Hernandez H., Hernández I., Heynngnezz L., Musachio A., Muzio V., Rodriguez A., Rodriguez F., Rodriguez M.C., Sánchez R., Serrano T., Toledo-Romani M.E., Toraño G., Verez-Bencomo V.Fuentes:scopus